Richard Gonzalez Unloads 4,799 Shares of AbbVie Stock

[Anonymous]

Wonder if our degree-less, fearless leader knows something we don't?

http://www.dailypolitical.com/2014/...lez-unloads-4799-shares-of-abbvie-stock-abbv/

 

[Anonymous]

Wonder if our degree-less, fearless leader knows something we don't?

http://www.dailypolitical.com/2014/...lez-unloads-4799-shares-of-abbvie-stock-abbv/

Bad news coming. Stay tuned here.

 

[Anonymous]

It's pretty rampant among many corporate insiders right now to dump stock. Leave the muppets holding the bag.

 

[Anonymous]

BFD. Upper management at both ABBV and ABT and every other 100 largest corps in America routinely exercise and then sell their stock options, and sell their RSUs (restricted stock units) that have vested every single quarter. It's normally set up automatically, so that they can prove it was not based on information that could be available only to insiders. It diversifies their investment portfolio. It is not a sign that any of the officers think something horrible is coming down the pike; if they did think so, they would just leave "to spend more time with their family" and move on down the road to another company.

 

[Anonymous]

BFD. Upper management at both ABBV and ABT and every other 100 largest corps in America routinely exercise and then sell their stock options, and sell their RSUs (restricted stock units) that have vested every single quarter. It's normally set up automatically, so that they can prove it was not based on information that could be available only to insiders. It diversifies their investment portfolio. It is not a sign that any of the officers think something horrible is coming down the pike; if they did think so, they would just leave "to spend more time with their family" and move on down the road to another company.

True, however, they can also not exercise the sale as well. Most CEOs, etc who truly believe that the investment is a good one will not sell. There is no law saying they have to. Yes it is set up automatically but is easy to stop prior to the execution date. Problem with abbvie is the decline of adrogel as it will soon face stiff generic competition as well as litigation, black box, doctors fears, etc. Although it may seem small , look at the last year, niaspan, trilipix, and now andro....lots of dollars sucked away...